Publications (original articles or review articles) published in 2023 from OUS - Research Institute of Internal Medicine
10 publications found
Pump-less, recirculating organ-on-a-chip (rOoC) platform
Lab Chip (in press)
DOI 10.1039/d2lc00919f, PubMed 36655405
Impact of the von Willebrand factor-ADAMTS13 axis on the risk of future venous thromboembolism
J Thromb Haemost (in press)
DOI 10.1016/j.jtha.2023.01.024, PubMed 36736832
In training or at work?
Tidsskr Nor Laegeforen, 143 (2)
DOI 10.4045/tidsskr.23.0031, PubMed 36718885
Environmental chemicals and endogenous metabolites in bile of USA and Norway patients with primary sclerosing cholangitis
Exposome, 3 (1), osac011
DOI 10.1093/exposome/osac011, PubMed 36687160
A multimorphic mutation in IRF4 causes human autosomal dominant combined immunodeficiency
Sci Immunol, 8 (79), eade7953
DOI 10.1126/sciimmunol.ade7953, PubMed 36662884
Transcriptional and functional effects of lithium in bipolar disorder iPSC-derived cortical spheroids
Mol Psychiatry (in press)
DOI 10.1038/s41380-023-01944-0, PubMed 36653674
"iPSC-derived liver organoids and inherited bleeding disorders: Potential and future perspectives"
Front Physiol, 14, 1094249
DOI 10.3389/fphys.2023.1094249, PubMed 36711019
Metabolic profiling of pregnancies complicated by preeclampsia: A longitudinal study
Acta Obstet Gynecol Scand (in press)
DOI 10.1111/aogs.14505, PubMed 36647289
Inflammatory markers and pulmonary function in adolescents and young adults 6 months after mild COVID-19
Front Immunol, 13, 1081718
DOI 10.3389/fimmu.2022.1081718, PubMed 36685555
Efficacy and safety of baricitinib in hospitalized adults with severe or critical COVID-19 (Bari-SolidAct): a randomised, double-blind, placebo-controlled phase 3 trial
Crit Care, 27 (1), 9
DOI 10.1186/s13054-022-04205-8, PubMed 36627655